The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Dosage form: capsule
Ingredients: IRON 150mg
Labeler: Nnodum Pharmaceuticals
NDC Code: 63044-203
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
(Polysaccharide-Iron Complex) Hematinic
WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep these products out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
IFEREX ™ 150 Capsules are a highly water soluble complex of iron and a low molecular weight polysaccharide.
ACTIONS AND USES: IFEREX™ 150 is an easily assimilated source of iron for treatment of uncomplicated iron deficiency anemia. Because IFEREX™ 150 is a polysaccharide bound iron complex, it is relatively nontoxic and there are relatively few, if any, gastrointestinal side effects associated with iron therapy, thus permitting full therapeutic dosage (150 - 300 mg elemental iron daily) in a single dose if desirable. There is no staining of teeth and no metallic aftertaste.
Iferex 150 is indicated for the prevention and treatment of iron deficiency anemia and / or nutritional megalobastic anemias.
In patients with hemochromatosis and hemosiderosis and in those with known hypersensitivity to any of the ingredients.
Adverse Reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools, and abdominal pain. Adverse reactions with iron therapy are usually transient.
Keep out of reach of children. Contains iron, which can be harmful or fatal to children in large doses.
Pediatric Use: Safety and effectiveness in pediatric patients has not been established.
Geriatric Use: Clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.
Adults - 1 to 2 capsules daily; pediatric patients, as directed by a physician.
IFEREX™ 150 Capsules are brown cap/opaque orange body imprinted “ZIKS” (Cap)/”0203” (body), NDC 63044-0203-61 Supplied in Unit Dose Packs containing 10 capsules per card.
Each capsule contains:
Iron (Elemental) . . . . . . . . . . . . . . . . . . . . . . . . . 150 mg
(as polysaccharide-iron complex)
Black Iron oxide,FD&C Red #28, FD&C Yellow # 10, FD&C blue #1, FD&C red #40, FD&C yellow #6, gelatin, magnesium stearate, microcrystalline cellulose,Red Iron Oxide, and Titanium Dioxide
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
Storage: Store at controlled room temperature 15°-30°C (59°-86°F).
Cincinnati, Ohio 45229
polysaccharide-iron complex capsule
|Labeler - Nnodum Pharmaceuticals (960457273)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.